RhD Prevention and Anti-D Prophylaxis: OB-GYN Review | MDster You are offline Back online! [ ](/) Specialities [ Anesthesiology ](https://mdster.com/speciality/anesthesiology) [ Emergency Medicine ](https://mdster.com/speciality/emergency-medicine) [ Family Medicine ](https://mdster.com/speciality/family-medicine) [ Internal Medicine ](https://mdster.com/speciality/internal-medicine) [ Obstetrics & Gynecology ](https://mdster.com/speciality/obstetrics-gynecology) [ Pediatrics ](https://mdster.com/speciality/pediatrics) [ Psychiatry ](https://mdster.com/speciality/psychiatry) [ Features ](https://mdster.com/features) [ Pricing ](https://mdster.com/pricing) [ Blog ](https://mdster.com/blog) Menu Specialities [ Anesthesiology ](https://mdster.com/speciality/anesthesiology) [ Emergency Medicine ](https://mdster.com/speciality/emergency-medicine) [ Family Medicine ](https://mdster.com/speciality/family-medicine) [ Internal Medicine ](https://mdster.com/speciality/internal-medicine) [ Obstetrics & Gynecology ](https://mdster.com/speciality/obstetrics-gynecology) [ Pediatrics ](https://mdster.com/speciality/pediatrics) [ Psychiatry ](https://mdster.com/speciality/psychiatry) [ Features ](https://mdster.com/features) [ Pricing ](https://mdster.com/pricing) [ Blog ](https://mdster.com/blog) [ Login ](https://mdster.com/auth/login) 1. [ Home ](https://mdster.com) 2. [ Blog ](https://mdster.com/blog) 3. [ Medical Education ](https://mdster.com/blog?category=medical-education) 4. RhD Immunization Prevention: Avoiding Missed Anti-D Prophylaxis [ Medical Education ](https://mdster.com/blog?category=medical-education) RhD Immunization Prevention: Avoiding Missed Anti-D Prophylaxis ================================================================= A board-focused guide to sensitizing events, prophylaxis timing, and when Kleihauer–Betke or flow cytometry changes management. [ MDster Editorial Team ](https://mdster.com/about) · Mar 31, 2026 · 6 min read · 47 [ Reviewed by Dr. Ali Ragab, MBBCH, MSc, MCAI ](https://mdster.com/medical-reviewers/dr-ali-ragab) [Editorial Policy](https://mdster.com/editorial-policy) | [Corrections Policy](https://mdster.com/corrections) [ Board Review ](https://mdster.com/blog?tag=board-review) [ Obstetrics & Gynecology ](https://mdster.com/blog?tag=obstetrics-gynecology) [ Obstetrics ](https://mdster.com/blog?tag=obstetrics) [ Immunohematology ](https://mdster.com/blog?tag=immunohematology) [ Rh Alloimmunization ](https://mdster.com/blog?tag=rh-alloimmunization) ![RhD Immunization Prevention: Avoiding Missed Anti-D Prophylaxis](https://mdster.com/storage/blog/images/rhd-immunization-prevention-avoiding-missed-anti-d-prophylaxis.jpg) Share this article Share this post You usually do not lose the Rh game because the science is hard. You lose it because prophylaxis is missed after a weekend bleed, an ECV, or a chaotic delivery. RhD prevention remains one of obstetrics’ genuine success stories, but only if the system catches every unsensitized RhD-negative patient before and after a sensitizing event. Once immune anti-D develops, prophylaxis is over and fetal surveillance begins. [\[1\]](#cite-1 "Reference [1]") Start With the Failure Modes ---------------------------- Sensitization happens when D-positive fetal RBCs enter maternal circulation and maternal immune memory is established. Delivery is the commonest immunizing event, but fetomaternal hemorrhage (FMH) also follows amniocentesis, CVS, abortion, ectopic rupture, abdominal trauma, fetal surgery, and silent third-trimester bleeds. Postpartum RhIG lowered alloimmunization from about 13–16% to 0.5–1.8%; adding routine antepartum prophylaxis dropped it further to about 0.14–0.2%. [\[2\]](#cite-2 "Reference [2]") The board-style pitfall is thinking failure equals “no postpartum dose.” More often, failure is one of four things: the 28-week dose was missed, a sensitizing event was not recognized, a large FMH overwhelmed a standard dose, or a positive anti-D screen was misclassified. Remember two high-yield rules: **RhIG does not help once immune anti-D is already present**, and **patients who have other antibodies but are still unsensitized to D still need anti-D prophylaxis**. [\[3\]](#cite-3 "Reference [3]") Know Exactly When to Give Anti-D -------------------------------- Prevention starts at booking with ABO/RhD typing and an antibody screen, then repeat screening at about 28 weeks before routine prophylaxis. In standard U.S. practice, give RhIG to the **unsensitized RhD-negative** patient at **28 weeks** and again **within 72 hours after delivery of an Rh-positive infant**. If fetal or paternal testing proves the fetus is RhD-negative, prophylaxis is unnecessary. [\[4\]](#cite-4 "Reference [4]") High-yield indications are easier to remember if you split them into routine, event-driven, and dose-escalation situations. SituationWhat to doRoutine antenatal prophylaxisGive RhIG at 28 weeks if unsensitized and RhD-negativePostpartum prophylaxisGive within 72 hours after birth of an Rh-positive infantSensitizing eventsGive after amniocentesis, CVS, fetal blood sampling or fetal surgery, ectopic pregnancy, abdominal trauma, bleeding after 20 weeks, and **after any ECV attempt**Not useful / not neededDo **not** give for established immune anti-D; do not give if the fetus is proven RhD-negative These are the routine exam-level indications, with the early-loss caveat discussed below. [\[4\]](#cite-4 "Reference [4]") The main gray zone in 2026 is pregnancy loss or abortion **before 12 weeks**. ACOG patient guidance recommends RhIG after miscarriage or abortion at **12 weeks or more** and says use before 12 weeks should be individualized; SMFM advises offering RhD testing and RhIG for spontaneous or induced abortion **under 12 weeks** when feasible and when it does not impede care. For exams, know the classic triggers, then know that very early loss is the area where local policy may differ. Ectopic pregnancy is **not** a gray zone; treat it as sensitizing. [\[4\]](#cite-4 "Reference [4]") Kleihauer–Betke and Flow Cytometry: Think “Dose Calculator,” Not Diagnosis -------------------------------------------------------------------------- Do not order a Kleihauer–Betke test because you suspect alloimmunization. Order FMH quantification because you think a **standard RhIG dose may be insufficient**. The traditional Kleihauer–Betke test is an acid-elution smear: fetal cells rich in HbF stain pink, whereas maternal cells appear as pale “ghost” cells. It is cheap and widely available, but it is imprecise and can overcall FMH when maternal HbF is elevated. [\[5\]](#cite-5 "Reference [5]") Flow cytometry does the same clinical job better. It labels and counts thousands of fetal cells, giving a more accurate estimate of FMH and therefore a better RhIG dose recommendation. One **300-mcg** dose covers about **30 mL of fetal whole blood** or **15 mL of fetal RBCs**. That is why postpartum testing after an Rh-positive delivery, or after major trauma or another high-risk event, matters: the issue is not whether to give RhIG, but whether **one vial is enough**. [\[2\]](#cite-2 "Reference [2]") > **Clinical Pearl:** A positive anti-D screen after recent prophylaxis is not automatically true alloimmunization. Call the transfusion lab before you label the patient sensitized and skip later RhIG. That single mistake can convert a preventable systems miss into a lifelong chart label and a high-risk future pregnancy. [\[3\]](#cite-3 "Reference [3]") Clinical Correlations --------------------- On labor and delivery, prevention is mostly about choreography. If the patient is RhD-negative, ask three questions every time something happens: **Is she already sensitized? Was this a sensitizing event? Do I need FMH quantification because the bleed might be large?** That framework catches the common misses after trauma, antepartum bleeding, procedures, ECV, and delivery. It also keeps you from the opposite error—ordering KB or flow when what the patient actually needs is the routine dose, on time. [\[4\]](#cite-4 "Reference [4]") Key Takeaways ------------- - **Routine prevention works**: 28-week RhIG plus postpartum prophylaxis has driven RhD sensitization rates down dramatically. [\[1\]](#cite-1 "Reference [1]") - **Missed events cause failures**: do not forget bleeding, trauma, procedures, ectopic pregnancy, and ECV. [\[4\]](#cite-4 "Reference [4]") - **RhIG is for the unsensitized patient**: immune anti-D means prophylaxis no longer helps. [\[3\]](#cite-3 "Reference [3]") - **KB and flow are dosing tools**: use them when you worry FMH exceeds the protection of a standard dose. [\[2\]](#cite-2 "Reference [2]") - **Early loss under 12 weeks is the nuance**: know your local protocol and know the current ACOG/SMFM split. [\[4\]](#cite-4 "Reference [4]") Conclusion ---------- RhD prevention is not complicated, but it is unforgiving. Type and screen early, give routine prophylaxis on time, treat sensitizing events aggressively, and use KB or flow cytometry when the bleed may be big. That is how you keep a board question from becoming fetal anemia in the next pregnancy. [\[4\]](#cite-4 "Reference [4]") Frequently Asked Questions ---------------------------- If the antibody screen is positive after the 28-week RhIG dose, is the patient already sensitized? Not necessarily. Passive anti-D from recent prophylaxis can make the screen positive; involve the transfusion laboratory before labeling immune anti-D or withholding future prophylaxis. [\[3\]](#cite-3 "Reference [3]") Does an unsuccessful external cephalic version still require anti-D prophylaxis? Yes. ACOG recommends RhIG after any ECV attempt in an unsensitized Rh-negative patient unless the fetus is known Rh-negative, the patient is already sensitized, or delivery will occur within 72 hours with FMH assessment. [\[6\]](#cite-6 "Reference [6]") When should I order Kleihauer–Betke testing or flow cytometry? Use FMH quantification after delivery of an Rh-positive infant or after a high-risk event when a large bleed is suspected, because one 300-mcg dose covers only about 30 mL of fetal whole blood or 15 mL of fetal RBCs. [\[2\]](#cite-2 "Reference [2]") What is the current nuance for pregnancy loss before 12 weeks? ACOG individualizes RhIG use before 12 weeks, whereas SMFM recommends offering RhD testing and RhIG when feasible and when it does not create barriers to care. [\[4\]](#cite-4 "Reference [4]") Does a patient with another alloantibody, such as anti-K, still need anti-D if she is RhD-negative? Yes, if she is RhD-negative and not already sensitized to D. The presence of a non-anti-D antibody does not remove the need for anti-D prophylaxis. [\[3\]](#cite-3 "Reference [3]") References (8) ------------------ 1. 1. [ ACOG Practice Bulletin No. 181: Prevention of Rh D Alloimmunization (2017; reaffirmed 2024) ](https://www.acog.org/clinical/clinical-guidance/practice-bulletin/articles/2017/08/prevention-of-rh-d-alloimmunization) [↩](#cite-ref-1-1 "Back to text") 2. 2. [ Mayo Clinic Laboratories: Fetomaternal Bleed, Flow Cytometry, Blood ](https://prenatal.testcatalog.org/show/FMB) [↩](#cite-ref-2-1 "Back to text") 3. 3. [ RCOG Green-top Guideline No. 65: The Management of Women with Red Cell Antibodies during Pregnancy ](https://www.rcog.org.uk/media/oykp1rtg/rbc_gtg65.pdf) [↩](#cite-ref-3-1 "Back to text") 4. 4. [ ACOG FAQ: The Rh Factor: How It Can Affect Your Pregnancy ](https://www.acog.org/womens-health/faqs/the-rh-factor-how-it-can-affect-your-pregnancy) [↩](#cite-ref-4-1 "Back to text") 5. 5. [ laboratories.newcastle-hospitals.nhs.uk/test-directory/kleihauer ](https://laboratories.newcastle-hospitals.nhs.uk/test-directory/kleihauer/) [↩](#cite-ref-5-1 "Back to text") 6. 6. [ www.acog.org/clinical/clinical-guidance/practice-bulletin/articles/2020/05/external-cephalic-version ](https://www.acog.org/clinical/clinical-guidance/practice-bulletin/articles/2020/05/external-cephalic-version) [↩](#cite-ref-6-1 "Back to text") 7. 7. [ Society for Maternal-Fetal Medicine Statement: RhD immune globulin after spontaneous or induced abortion less than 12 weeks of gestation (2024) ](https://publications.smfm.org/publications/551-society-for-maternal-fetal-medicine-statement-rhd-immune/) 8. 8. [ RCOG Green-top Guideline No. 22: The Use of Anti-D Immunoglobulin for Rhesus D Prophylaxis ](https://www.rcog.org.uk/guidance/browse-all-guidance/green-top-guidelines/the-use-of-anti-d-immunoglobulin-for-rhesus-d-prophylaxis-green-top-guideline-no-22/) Next step Build confidence in OB/GYN with focused practice -------------------------------------------------- - Labor & delivery + postpartum essentials - Gynecology, screening, and common procedures - Review weak topics and improve faster [ Start practicing ](https://mdster.com/user/dashboard) [ Explore Obstetrics & Gynecology ](https://mdster.com/speciality/obstetrics-gynecology) [ View pricing ](https://mdster.com/pricing) [ Explore features ](https://mdster.com/features) No credit card required. Full access to all features. No commitment. Cancel anytime. [ Back to all posts ](https://mdster.com/blog) Discussion () ----------------- Join the discussion [ Log in ](https://mdster.com/auth/login) or [ Sign up ](https://mdster.com/auth/register) No comments yet Be the first to share your thoughts! ![]() Related Posts ------------- [ ![Anxiety, Depression, and Breathlessness in Severe COPD/Asthma Overlap](https://mdster.com/storage/blog/images/anxiety-depression-and-breathlessness-in-severe-copdasthma-overlap.jpg) Medical Education ### Anxiety, Depression, and Breathlessness in Severe COPD/Asthma Overlap A focused Family Medicine review of anxiety, depression, and dyspnea in severe COPD/asthma overlap, with safer prescribing, breathing retraining, and board-style pitfalls. 6 min read 0 comments ](https://mdster.com/blog/anxiety-depression-and-breathlessness-in-severe-copdasthma-overlap) [ ![Neonatal Septic Shock in the ED: A High-Yield Case Discussion](https://mdster.com/storage/blog/images/neonatal-septic-shock-in-the-ed-a-high-yield-case-discussion.jpg) Case Discussion ### Neonatal Septic Shock in the ED: A High-Yield Case Discussion An ill 18-day-old with fever, lethargy, shock, and hypoglycemia demands parallel resuscitation and sepsis management. This case reviews ED priorities, LP timing, antibiotics, HSV coverage, and board pearls. 6 min read 0 comments ](https://mdster.com/blog/neonatal-septic-shock-in-the-ed-a-high-yield-case-discussion) [ ![IBS Subtypes and Diagnosis: Rome IV, IBS-C/D, and Colonoscopy](https://mdster.com/storage/blog/images/ibs-subtypes-and-diagnosis-rome-iv-ibs-cd-and-colonoscopy.jpg) Medical Education ### IBS Subtypes and Diagnosis: Rome IV, IBS-C/D, and Colonoscopy A focused Internal Medicine review of IBS diagnosis: how to use Rome IV concepts, separate IBS-C from IBS-D and mixed IBS, and decide when colonoscopy is truly indicated. 7 min read 0 comments ](https://mdster.com/blog/ibs-subtypes-and-diagnosis-rome-iv-ibs-cd-and-colonoscopy) [ ](/) Master your medical exams with evidence-based learning. [ GET IT ON Google Play ](https://play.google.com/store/apps/details?id=com.mdster.app) ### Platform - [Home](https://mdster.com) - [Features](https://mdster.com/features) - [Pricing](https://mdster.com/pricing) - [About](https://mdster.com/about) ### Resources - [Blog](https://mdster.com/blog) - [Dashboard](https://mdster.com/user/dashboard) ### Support - [Contact](https://mdster.com/contact) - [Legal & Policies](https://mdster.com/legal) - [Medical Reviewers](https://mdster.com/medical-reviewers) © 2026 MDster [ ](https://play.google.com/store/apps/details?id=com.mdster.app) [Terms](https://mdster.com/terms) [Privacy](https://mdster.com/privacy) [Editorial](https://mdster.com/editorial-policy) reCAPTCHA Protected by reCAPTCHA. Google [Privacy Policy](https://policies.google.com/privacy) and [Terms of Service](https://policies.google.com/terms) apply. Cookie Consent -------------- We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. [ Terms of Use ](https://mdster.com/terms) & [ Privacy Policy ](https://mdster.com/privacy) Accept